pharmaphorum

JANUARY 24, 2022

Francisco Partners is picking up a range of databases and analytics tools – including Health Insights, MarketScan, Clinical Development, Social Programme Management, Micromedex and other imaging and radiology tools – for an undisclosed sum estimated to be in the region of $1 billion.

Cerner 111

Cerner 111

pharmaphorum

NOVEMBER 24, 2022

Johnson & Johnson’s Spravato therapy for treatment-resistant depression (TRD) hasn’t made the impact the company hoped for in the market, and it is looking to new clinical results to accelerate its take-up. The post J&J builds case for antidepressant Spravato with head-to-head trial appeared first on.

Labelling 52

Labelling Hospitals 52

pharmaphorum

AUGUST 18, 2022

The US approval comes three years after Zynteglo (betibeglogene autotemcel) was approved for the same indication in Europe, and subsequently withdrawn after bluebird concluded that it wasn’t possible to build a commercially viable business for the gene therapy as the pricing and reimbursement environment there was too “hostile.”

FDA 52

FDA Insurance 52

The Spirit Pharmacist

DECEMBER 2, 2021

Psychedelic therapies are making headlines due to the unprecedented benefits demonstrated in clinical trials for persons with refractory mental illnesses. However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies.

Health and Personal Care Stores 52

Health and Personal Care Stores Insurance Coverage Insurance Patient Care 52

Pharmaceutical Technology

APRIL 5, 2023

But access to these treatments continues to remain limited due to high price tags and variable availability across regions. This approach remains logistically complex, which builds the desire for allogeneic treatments that can be manufactured from unrelated donors on a larger scale.

FDA 59

FDA Immunization 59

The Checkup by Singlecare

NOVEMBER 2, 2023

If a drug is FDA approved for a particular purpose, that means the Food and Drug Administration (FDA) has deemed the drug to be effective for that purpose, based on reviewing extensive data from clinical trials supporting its use. A 2020 clinical trial demonstrates this point. The high price tag is a barrier for many people.

Insurance 52

Insurance FDA Adverse Reactions Hospitals 52

pharmaphorum

OCTOBER 4, 2022

During the first stage of the initiative, more than 2,000 research papers were published, 49 clinical trials were carried out, and more than 30 patents were filed through the support of the US National Cancer Institute (NCI). Building a bank. Informed consent is crucial to recruiting the patient to the study. Up in the clouds.

Documentation 102

Documentation Data Entry HIPAA Insurance 102